Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo
Tumor antigen-encoding mRNA for dendritic cell (DC)-based vaccination has gained increasing popularity in recent years. Within this context, two main strategies have entered the clinical trial stage: the use of mRNA for ex vivo antigen loading of DCs and the direct application of mRNA as a source of...
Saved in:
Main Authors: | Daphné Benteyn (Author), Sébastien Anguille (Author), Sandra Van Lint (Author), Carlo Heirman (Author), An MT Van Nuffel (Author), Jurgen Corthals (Author), Sebastian Ochsenreither (Author), Wim Waelput (Author), Katrien Van Beneden (Author), Karine Breckpot (Author), Viggo Van Tendeloo (Author), Kris Thielemans (Author), Aude Bonehill (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice
by: Rachel L. Berry, et al.
Published: (2015) -
Antitumor effect of oral cancer vaccine with Bifidobacterium delivering WT1 protein to gut immune system is superior to WT1 peptide vaccine
by: Toshiro Shirakawa, et al.
Published: (2018) -
Molecular mechanism of Wilms' tumor (Wt1) (+/−KTS) variants promoting proliferation and migration of ovarian epithelial cells by bioinformatics analysis
by: Xiaomei Wang, et al.
Published: (2023) -
Bilateral Wilms' tumors in an infant with Denys-Drash syndrome and rarely seen truncation mutation in the WT1 gene-exon 6
by: Jayesh Modi, et al.
Published: (2015) -
Immunoreactivity of Wilms tumor 1 (WT1) as an additional evidence supporting hemangiomatous rather than inflammatory origin in the etiopathogenesis of angiolymphoid hyperplasia with eosinophilia
by: Fatma Tokat, et al.
Published: (2018)